ACTR-56. A 2-PART SAFETY AND EXPLORATORY EFFICACY RANDOMISED DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A 1:1 RATIO OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL (CBD:THC) PLUS DOSE-INTENSE TEMOZOLOMIDE IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.